Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.13 - $8.83 $3.89 Million - $11 Million
-1,244,266 Reduced 65.71%
649,434 $2.16 Million
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $189,853 - $305,964
32,343 Added 1.74%
1,893,700 $16 Million
Q4 2021

Feb 14, 2022

BUY
$7.88 - $18.03 $12,529 - $28,667
1,590 Added 0.09%
1,861,357 $15.3 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $19.3 Million - $56.3 Million
1,859,767 New
1,859,767 $21.6 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.